Carbohydrate modified ultrafine ceramic nanoparticles for allergen immunotherapy

International Immunopharmacology

Volumn 11, Issue 8, 2011, Pages 925-931

  Pandey, Ravi Shankar ^a,b   Sahu, Satish ^a   Sudheesh, M S ^a   Madan, Jitender ^c   Kumar, Manoj ^b   Dixit, Vinod Kumar ^a  

^a Dr Hari Singh Cour Vishwavidyalaya   (India)

^b GURU GHASIDAS UNIVERSITY   (India)

^c Hindu College   (India)

Author keywords

Allergy Aquasomes Ceramic; Specific immunotherapy

Indexed keywords

ALUMINUM HYDROXIDE; AQUASOME; CARBOHYDRATE; DRUG VEHICLE; HYDROXYAPATITE; NANOPARTICLE; OVALBUMIN; UNCLASSIFIED DRUG;

ANAPHYLACTIC SHOCK; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELLULAR IMMUNITY; CERAMICS; FEMALE; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOTHERAPY; MOUSE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; PROVOCATION TEST; ZETA POTENTIAL;

EID: 84860389292     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2011.02.004     Document Type: Article

References (31)

1. Broos S, Lundberg K, Akagi T, Kadowaki K, Akashi M, Greiff L, et al. Immunomodulatory nanoparticles as adjuvants and allergen-delivery system to human dendritic cells: implications for specific immunotherapy. Vaccine 2010;28(31): 5075-85.
2. Kündig TM, Bachmann MF. Allergen-specific immunotherapy: regulatory T cells or allergen-specific IgG? Hum Vaccin 2010;6(8):673-5.
3. Frew AJ. Allergen immunotherapy. J Allergy Clin Immunol 2010;25(2 Suppl 2): S306-13.
4. Akdis M, Akdis CA. Mechanisms of allergen-specific immunotherapy. J Allergy Clin Immunol 2007;119(4):780-91.
5. Bousquet J, Lockey R, Malling HJ. Allergen immunotherapy: therapeutic vaccines for allergic diseases. AWHO position paper. J Allergy Clin Immunol 1998;102: 558-62.
6. Rolland JM, Gardner LM, O'Hehir RE. Allergen-related approaches to immunotherapy. Pharmacol Ther 2009;121(3):273-84.
7. San Román B, Irache JM, Gómez S, Gamazo C, Espuelas S. Co-delivery of ovalbumin and CpG motifs into microparticles protected sensitized mice from anaphylaxis. Int Arch Allergy Immunol 2009;149(2):111-8.
8. Schöll I, Weissenböck A, Förster-Waldl E, Untersmayr E, Walter F, Willheim M, et al. Allergen-loaded biodegradable poly(D, L-lactic-co-glycolic) acid nanoparticles down-regulate an ongoing Th2 response in the BALB/c mouse model. Clin Exp Allergy 2004;34(2):315-21. (Pubitemid 38315270)
9. Gómez S, Gamazo C, San Roman B, Grau A, Espuelas S, Ferrer M, et al. A novel nanoparticulate adjuvant for immunotherapy with Lolium perenne. J Immunol Methods 2009;348(1-2):1-8.
10. Chew JL, Wolfowicz CB, Mao HQ, Leong KW, Chua KY. Chitosan nanoparticles containing plasmid DNA encoding house dust mite allergen, Der p 1 for oral vaccination in mice. Vaccine 2003;21(21-22):2709-20.
11. Kossovsky N, Gelman A, Rajguru S, Nguych R, Sponsler EE, Hantyszyn HJ, et al. Control of molecular polymorphisms by a structured carbohydrate/ceramic delivery vehicle-aquasomes. J Control Release 1996;39(2-3):383-8. (Pubitemid 26195840)
12. Goyal AK, Khatri K, Mishra N, Mehta A, Vaidya B, Tiwari S, et al. Aquasomes-a nanoparticulate approach for the delivery of antigen. Drug Dev Ind Pharm 2008;34 (12):1297-305.
13. Umashankar MS, Sachdeva RK, Gulati M. Aquasomes: a promising carrier for peptides and protein delivery. Nanomedicine 2010;6(3):419-26.
14. Arakawa T, Timasheff SN. Stabilization of protein structure by sugars. Biochemistry 1982;21(25):6536-44.
15. Kossovsky N, Gelman A, Sponsler E, Rajguru S, Torres M, Mena E, et al. Preservation of surface-dependent properties of viral antigens following immobilization on particulate ceramic delivery vehicles. J Biomed Mater Res 1995;29(5):561-73.
16. Goyal AK, Rawat A, Mahor S, Gupta PN, Khatri K, Vyas SP. Nanodecoy system: a novel approach to design hepatitis B vaccine for immunopotentiation. Int J Pharm 2006;309(1-2):227-33. (Pubitemid 43129486)
17. Zhang YJ, Lu JJ. A simple method to tailor spherical nanocrystal hydroxyapatite at low temperature. J Nanopart Res 2007;9:589-94.
18. Hedge JE, Hofreiter BT. Estimation of polysaccharide. In: Whistler RL, Be Miller JN, editors. Methods in carbohydrate chemistry. New York: Academic Press; 1962. p. 445.
19. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227(5259):680-5.
20. Pandey RS, Dixit VK. Evaluation of ISCOM vaccines for mucosal immunization against hepatitis B. J Drug Target 2010;18(4):282-91.
21. Roman BS, Espuelas S, Gómez S, Gamazo C, Sanz ML, Ferrer M, et al. Intradermal immunization with ovalbumin-loaded poly-epsilon-caprolactone microparticles conferred protection in ovalbumin-sensitized allergic mice. Clin Exp Allergy 2007;37(2):287-95. (Pubitemid 46148287)
22. Gómez S, Gamazo C, San Roman B, Ferrer M, Sanz ML, Espuelas S, et al. Allergen immunotherapy with nanoparticles containing lipopolysaccharide from Brucella ovis. Eur J Pharm Biopharm 2008;70(3):711-7.
23. Kossovsky N, Gelman A, Sponsler EE, Hnatyszyn HJ, Rajguru S, Torres M, et al. Surface modified nanocrystalline ceramics for drug delivery applications. Biomaterials 1994;15:1201-7.
24. Oonishi H. Orthopaedic applications of hydroxyapatite. Biomaterials 1991;12: 171-8.
25. Paul W, Sharma CP. Ceramic drug delivery: a perspective. J Biomater Appl 2003;17:253-64.
26. Barroug A, Lernoux E, Lemaitre J, Rouxhet PG. Adsorption of catalase on hydroxyapatite. J Colloid Interface Sci 1998;208:147-52. (Pubitemid 28563540)
27. Tas AC. Synthesis of biomimetic Ca-hydroxyapatite powders at 37 °C in synthetic body fluids. Biomaterials 2000;21:1429-38.
28. Patil S, Pancholli SS, Agrawal S, Agrawal GP. Surface-modified mesoporous ceramics as delivery vehicle for haemoglobin. Drug Deliv 2004;11:193-9. (Pubitemid 38720416)
29. He Q, Mitchell AR, Johnson ST, Wagner-Bartak C, Morcol T, Bell SJD. Calcium phosphate nanoparticle adjuvant. Clin Diagn Lab Immunol 2000;7:899-903. (Pubitemid 32244486)
30. Goyal AK, Khatri K, Mishra N, Mehta A, Vaidya B, Tiwari S, et al. Development of self-assembled nanoceramic carrier construct(s) for vaccine delivery. J Biomater Appl 2009;24(1):65-84.
31. BioSante Pharmaceuticals. Calcium phosphate nanoparticles (CAP). http://www. biosantepharma.com/products/cap.html 2007.